ZAI LAB
Zai Lab is an innovative biopharmaceutical company based in Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. Since their founding in 2014, their experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates. They see theirselves as the trusted partner of choice for global biopharmaceutical companies seeking to access the C... hinese market. Leveraging their team’s extensive global drug development expertise, combined with their demonstrated understanding of the pharmaceutical industry, the increasingly favorable clinical and regulatory environment in China and their in-house manufacturing capabilities, they plan to continue to secure relationships with global pharmaceutical companies to further expand their pipeline and foster innovation in China. Their team is passionate about bringing transformative new medicines to patients. Their vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing their partner’s and their own products in China and around the world. To that end, they have built manufacturing capabilities to support the clinical and commercial production of their drug candidates in China, and they expect to have further clinical production capabilities in the near future. Their team is planning to establish a specialized commercial team to support marketing of their products in China and beyond, and they are expanding their discovery efforts both internally and through collaborations with leading academic institutions.
ZAI LAB
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.zailaboratory.com
Total Employee:
1001+
Status:
Active
Contact:
+86 21 6163 2588
Total Funding:
2.01 B USD
Technology used in webpage:
Domain Not Resolving Font Awesome IPv6 Google Universal Analytics Microsoft IIS 10 PHP 7 Amazon Route 53 ASP.NET 4.0 Microsoft Azure
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
I-Mab Biopharma
I-Mab is a dynamic and fast-growing global biotech company exclusively focused on developing innovative biologics.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Inovio Pharmaceuticals
Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.
Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Ocon Healthcare
Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women’s health and quality of life
PharmNovo
PharmNovo addresses the high unmet need of treatments for chronic pain, which affects up to 30% of the adult population in the USA & Europe.
ROME Therapeutics
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
SAI Life Sciences
SAI Life Sciences delivers advanced Discovery, Contract Development and Manufacturing Solutions.
WuXi AppTec
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Current Advisors List
Board_member
2014-01-01
Current Employees Featured
Peter Huang Chief Scientific Officer @ Zai Lab
Chief Scientific Officer
2022-11-01
Samantha DU Founder, CEO, & Chair @ Zai Lab
Founder, CEO, & Chair
2014-01-01
Yongjiang Hei Chief Medical Officer, Oncology @ Zai Lab
Chief Medical Officer, Oncology
2018-08-01
Yingyong Xu Vice President of Medical (Oncology) @ Zai Lab
Vice President of Medical (Oncology)
2022-09-01
Linda Liu SVP, Biologics Discovery @ Zai Lab
SVP, Biologics Discovery
2022-02-01
Harald Reinhart Chief Medical Officer, Autoimmune and Infectious Diseases @ Zai Lab
Chief Medical Officer, Autoimmune and Infectious Diseases
William Liang Chief Commercial Officer & President of Greater China @ Zai Lab
Chief Commercial Officer & President of Greater China
2018-06-01
Founder
Stock Details
Investors List
Vivo Capital
Vivo Capital investment in Series C - Zai Lab
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Zai Lab
OrbiMed
OrbiMed investment in Series C - Zai Lab
Rock Springs Capital
Rock Springs Capital investment in Series C - Zai Lab
Qiming Venture Partners
Qiming Venture Partners investment in Series C - Zai Lab
Sequoia Capital China
Sequoia Capital China investment in Series B - Zai Lab
Qiming Venture Partners
Qiming Venture Partners investment in Series B - Zai Lab
OrbiMed
OrbiMed investment in Series B - Zai Lab
Advantech Capital
Advantech Capital investment in Series B - Zai Lab
TF Capital
TF Capital investment in Series B - Zai Lab
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2016-12-01 | dMed | Zai Lab investment in Series A - dMed | 8 M USD |
Key Employee Changes
Date | New article |
---|---|
2023-07-06 | Zai Lab promotes Yajing Chen to CFO, succeeding Billy Cho |
2022-11-08 | Zai Lab Announces the Appointment of Dr. Peter Huang as Chief Scientific Officer |
Official Site Inspections
http://www.zailaboratory.com Semrush global rank: 2.91 M Semrush visits lastest month: 5.51 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Zai Lab"
About Zai Lab - Zai Lab
Zai Lab is a patient-focused, innovative, commercial-stage, global biopharmaceutical company based in China and the U.S. We are focused on bringing best-in-class and first-in-class medicines for oncology, immunology, …See details»
What We Do - Zai Lab
Our strengths are the global experience within our organization in innovative drug R&D, our broad product portfolio and pipeline, and our track record of execution with speed and quality in …See details»
Zai Lab - LinkedIn
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing transformative products ...See details»
Investor Overview – Zai Lab Limited
Mar 11, 2025 christine.chiou1@zailaboratory.com. Lina Zhang, VP, Corporate Strategy and Capital Markets lina.zhang@zailaboratory.com. Media Inquiries Shaun Maccoun, Executive …See details»
Zai Lab - Crunchbase Company Profile & Funding
Contact Email info@zailaboratory.com Phone Number +86 21 6163 2588 Zai Lab is an innovative biopharmaceutical company based in Shanghai focused on bringing transformative medicines for cancer, autoimmune and infectious …See details»
Zai Lab - Company Profile
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing …See details»
首页 - 再鼎医药
再鼎医药的使命是为全球患者带来创新疗法、解决未满足的医疗需求。在公司快速发展壮大的过程中,我们始终欢迎与再鼎医药志同道合、充满热忱并有合作精神的优秀人才的加入。See details»
ZAI Lab Company Profile - Office Locations, Competitors ... - Craft
Oct 28, 2024 ZAI Lab has 5 employees across 7 locations and $266.72 m in annual revenue in FY 2023. See insights on ZAI Lab including office locations, competitors, revenue, financials, …See details»
Zai Lab Announces First Quarter 2024 Financial Results and Recent ...
May 8, 2024 Net product revenue of $87.1 million for the first quarter of 2024, representing 39% y-o-y growth; 43% y-o-y growth at constant exchange rate (CER); VYVGART ® (efgartigimod …See details»
Our R&D - Zai Lab
Notes: The trademarks and registered trademarks within are the property of their respective owners. *Greater China trial in preparation or under planning. Greater China = mainland …See details»
James Yan – Management – Zai Lab Limited
Prior to Zai Lab, Dr. Yan was the Executive Director of Covance Inc. and the Head of Covance Early Development, Shanghai Site, where he was responsible for all aspects of the business …See details»
Zai Lab Information - RocketReach
Zai Lab is an innovative, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing …See details»
Zai Lab - LinkedIn
Zai Lab | 25,206 followers on LinkedIn. Delivering innovative, transformational outcomes to patients around the world | Zai Lab is an innovative, commercial-stage biopharmaceutical …See details»
Zai Lab - Overview, News & Similar companies | ZoomInfo.com
May 12, 2024 www.zailaboratory.com. Revenue $291.1 Million. Stock Symbol ZLAB. Industry Medical Devices & Equipment Manufacturing . Most Recent Scoops. May 13 2024. Earnings. …See details»
Zai Lab Announces Second Quarter 2024 Financial Results and …
Nov 11, 2024 Our efforts to build a stronger and more efficient organization, coupled with our innovative pipeline, position us for substantial topline growth and set us on the path to achieve …See details»
Zai Lab to Present New Data from Internally Developed
1 day ago Our SEC filings can be found on our website at www.zailaboratory.com and on the SEC’s website at www.SEC.gov. Investor Relations: Christine Chiou / Lina Zhang +1 (917) …See details»
Zai Lab Announces the Appointment of Josh Smiley as Chief …
Mar 15, 2022 Mr. Smiley began his career at Lilly in 1995, holding leadership positions across the organization culminating in his most recent role of Senior Vice President and Chief …See details»
Zai Lab Announces Fourth Quarter and Full Year 2024
Feb 27, 2025 Total revenues grew 66% y-o-y to $109.1 million for the fourth quarter of 2024 and 50% y-o-y to $399.0 million for the full-year 2024; Full-year 2025 revenue guidance of $560 …See details»
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial …
Feb 27, 2025 Total revenues grew 66% y-o-y to $109.1 million for the fourth quarter of 2024 and 50% y-o-y to $399.0 million for the full-year 2024; Full-year 2025 revenue guidance of $560 …See details»
Zai Lab Announces Fourth Quarter and Full Year 2024 Financial …
Feb 27, 2025 Our SEC filings can be found on our website at www.zailaboratory.com and on the SEC’s website at www.SEC.gov. Zai Lab Limited. Consolidated Balance Sheets (in thousands …See details»